Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06826092 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 13, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
To investigate progression-free survival (PFS) in patients with metastatic colorectal cancer treated with chemotherapy FOLFIRI monotherapy or chemotherapy FOLFIRI combined with Metformin
Trial Details
NCT Number NCT06826092
Lead Sponsor Kaohsiung Medical University Chung-Ho Memorial Hospital
Conditions
(from sponsor)		 Progression-Free Survival
Enrollment 110 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov